MODERNA, INC.

MRNA

Real-time Estimate Cboe BZX - 11:14 2022-12-07 am EST
179.74 USD	+3.57%

Turn to zoom

Prev.	173.54000000
Open	172.31000000
High	180.23000000
Low	171.85000000
Volume	1 065 349

22h ago	EU regulator backs bivalent COVID shots for primary vaccination
23h ago	EU regulator backs bivalent COVID vaccines for primary vaccination
23h ago	Global markets live: Vodafone, PepsiCo, Microsoft, Implenia, Pfizer...
1d ago	It just doesn't add up

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Neutral
Resistance	185	194	254
Spread/Res.	-3,3%	-7,6%	-29%
Spread/Supp.	9,9%	53%	52%
Support	163	117	118

Sales 2022	19 089 M - -
Net income 2022	8 897 M - -
Net cash 2022	12 022 M - -
P/E ratio 2022	8,05x
Yield 2022	-

Capitalization	66 671 M 66 671 M -
EV / Sales 2022	2,86x
EV / Sales 2023	6,03x
Nbr of Employees	2 700
Free-Float	90,3%

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
-...

Sector :

Other Biotechnology & Medical Research

Calendar :

2023-02-23 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	19
Last Close Price	173,54 $
Average target price	211,25 $
Spread / Average Target	21,7%